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Low Cholesterol is Associated with Mortality from Cardiovascular 
Diseases: A Dynamic Cohort Study in Korean Adults
This study was conducted to evaluate the association of single serum total cholesterol (TC) 
measurement with cardiovascular diseases (CVD) deaths in Korean adults. The study 
subjects were taken from the multi-site collaborative dynamic prospective cohort for 
epidemiologic investigation on cancer risk in residents nearby nuclear power plants in 
Korea. A total of 12,740 adults aged 40 to 69 yr who underwent a mass screening 
examination were followed up from 1993 to 2008. Occurring CVD deaths were confirmed 
by the death certificates in the National Statistical Office, Korea. Groups with the lowest 
group having TC < 160 mg/dL as well as the highest group having >= 240 mg/dL were 
associated with higher CVD mortality in Cox proportional hazards analysis adjusting for 
age, sex, smoking and drinking status, body mass index, level of blood pressure, 
triglyceride and high density lipoprotein cholesterol. The distribution of adjusted hazard 
ratios showed the U-shaped curve. Based on the results of this study, caution should be 
taken in prescribing statins for primary prevention among people at low cardiovascular risk 
in Korean adults. 
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ORIGINAL ARTICLE
Cardiovascular Disorders
INTRODUCTION
Cardiovascular diseases (CVD) are the world’s largest killers, 
claiming 17.1 million lives a year (1). As a paradigm shift was 
needed into the management of comprehensive CVD risk, WHO 
(2) has recommended total cholesterol (TC) as the only lipid 
parameter for CVD risk assessment of individuals detected to 
have hypertension, diabetes or smoking behavior in low and 
medium resource settings where it is both time-consuming and 
costly to measure TC, TG, LDL-C and HDL-C altogether. A single 
measurement of TC in middle aged retains its information in 
being associated with coronary heart disease (CHD) events and 
predicts them with similar or only slightly decreasing, strength 
for a long period of time (3, 4), it is confirmed that the magni-
tude of multivariate coefficients for serum cholesterol in predict-
ing coronary events is similar across different populations, char-
acterized by different cholesterol levels and different death rates 
from CHD (5). Thus, reducing high blood cholesterol, a risk fac-
tor for CVD events in people with and without a past history of 
CHD is an important goal of pharmacotherapy (6).
  However, the relation of cholesterol to total mortality and non-
CVD mortality varied by country and gender in contrast to CHD 
mortality (7). The shape of the relationship between total cho-
lesterol and non-CHD mortality has been inconsistent (8). In 
addition, a Japanese study concluded that high cholesterol was 
not a risk factor for CVD mortality while low cholesterol was re-
lated to high mortality (9). The purpose was to study the associa-
tion of a single serum cholesterol measurement with CVD deaths 
in Korean adults by a prospective cohort study.
 
MATERIALS AND METHODS
Cohort construction
The study participants were taken from the cohort for epidemi-
ologic investigation on cancer risk in residents nearby nuclear 
power plants in Korea (10). Subjects were residents in Youngk-
wang, Wolsung, Kori, Uljin, Chungju, Yangpyong, and Haman 
County. This multi-sites collaborative dynamic prospective co-
hort was constructed between 1992 and 2005 with a total follow-
up of 303,542 person-years in 36,176 subjects. Because nuclear 
power plants in Korea were mainly located in countryside, the 
enrollee of this cohort was represented in a population of rural 
district rather than of urban. All subjects provided written in-
formed consent. And this study has approved by the institutional 
review board of Seoul National University College of Medicine 
(IRB No. C-0611-012-188).
  The three exclusion criteria from the cohort were applied to 
construct the study participants: first, members without mea-Bae J-M, et al.  •  Low Cholesterol & CVD Mortality in Korean Adults
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surement of total cholesterol (TC) levels (n = 16,330); second, 
members aged under 40- or over 70 yr old (n = 5,718); last, mem-
bers having previous history of cardiovascular diseases on entry 
(n = 1,388). Finally 12,740 subjects were selected as the study 
subjects. 
  Baseline demographic and clinical data were obtained from 
interviewer-administrated questionnaires. Weight and height 
were measured in wearing light clothing. Subjects were seated 
for blood-pressure measurement. Non-fasting blood specimens 
were drawn in order to determine total cholesterol (TC), triglyc-
eride (TG), and high-density lipoprotein (HDL) cholesterol. Qual-
ity-control procedures were achieved in agreement with the Ko-
rean Association of Laboratory Quality Control.
Follow-up and Outcome Ascertainment
Deaths among study participants through December 31, 2008, 
were confirmed by linking the information to the death certifi-
cates in the Statistics Korea (11). The death from cardiovascular 
diseases was confirmed from abstractors’ coded causes of death 
by the ‘I00’ to ‘I69’ in Korea Standard Classification of Cause of 
Death (KCD), 6th Revision (12). To conduct the subgroup anal-
ysis, deaths from heart diseases and stroke were defined by a 
combination of KCD codes ‘I00’ to ‘I52’, and ‘I60’ to ‘I69’, respec-
tively. 
  Total person-years were calculated by determining the num-
ber of days from the entry, until the date of death from CVD, or 
the end of follow-up, 31 December 2008, after which the num-
ber of days was converted into years. 
Data analysis
Subjects were divided into 4 groups based on the cutoff value of 
160, 200, 240 mg/dL in TC level. The cutoff value of TC used was 
selected on the basis of past research (9) for comparing results, 
while the cut-points of TG and HDL were obtained from 25th, 
50th, and 75th percentile in distribution. The second lowest group 
(160-199 mg/dL) in TC and TG was used as the reference group. 
  A potential confounder among the variables of the baseline 
information was defined as a variable showing a statistical signif-
icance based on the crude hazard ratios (cHR) of deaths from 
CVD. By this definition, the following eight potential confound-
ers were chosen: age, sex, current smoking/drinking habit on 
entry, body mass index and distribution of blood pressure, as 
Table 1. The crude hazard ratio (cHR) with 95% confidence intervals (CIs) of baseline characteristics in death by cardiovascular diseases in the study participants (n = 12,740)*
Variables Deaths No. cHR 95% CI P value (χ2 trend)
Age (yr)
   40-49
   50-59
   60-69
 
9
37
127
 
3,277
4,204
5,259
 
1.00
3.27
3.14
 
 
[1.58, 6.78]
[4.65, 17.97]
< 0.001
Sex 
   Male
   Female 
 
98
75
 
4,882
7,858
 
1.00
0.46
 
[0.34, 0.62]
< 0.001
Smoking history
   No
   Quit 
   Yes
 
73
22
72
 
8,179
1,479
2,893
 
1.00
1.59
2.76
 
  
[0.99, 2.56]
[2.00, 3.79]
< 0.001
Drinking history
   No
   Quit 
   Yes
 
71
14
81
 
6,938
749
4,842
 
1.00
1.77
1.56
 
  
[1.00, 3.13]
[1.14, 2.13]
< 0.001
Body mass index
   Normal
   Thin
   Overweight
   Obesity
 
71
51
29
5
 
4,973
1,733
3,543
545
 
1.00
2.42
0.64
0.72
 
  
[1.71, 3.42]
[0.42, 0.97]
[0.29, 1.77]
< 0.001
Level of blood pressure
   Normal
   Prehypertension
   Hypertension
 
17
39
117
 
2,332
4,151
6,257
 
1.00
1.29
2.59
 
  
[0.73, 2.28]
[1.56, 4.31]
< 0.001
Triglyceride (mg/dL)
   < 90
   90-127
   128-188
   189-
 
22
95
28
28
 
2,217
5,854
2,283
2,386
 
1.68
1.00
1.23
1.18
  
[1.06, 2.67]
  
[0.71, 2.16]
[0.68, 2.07]
< 0.001
High density lipoprotein (mg/dL)
   59-
   50-58
   42-49
   < 41
 
17
25
25
106
 
2,193
2,284
2,391
5,872
 
1.00
1.41
1.34
2.39
  
 
[0.76, 2.61]
[0.73, 2.49]
[1.43, 3.99]
< 0.001
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well as level of TG and HDL cholesterol (Table 1). Because TG 
and HDL cholesterol are highly correlated to TC, another mod-
el excluding TG and HDL was applied in multivariable analysis 
for considering over-adjustment.
  Age at entry was categorized into 10-yr groups of 40-49, 50-59, 
and 60-69 yr old. The other confounding factors were catego-
rized such as current smoking/drinking habit on entry (no/quit/ 
yes), body mass index (BMI; thin, normal, overweight, and obe-
sity) and distribution of blood pressure (normal, pre-hyperten-
sion, and hypertension). The BMI was categorized as less than 
20.0, 20.0 to 24.9, 25.0 to 29.9, and 30.0 or more. The blood pres-
sure was grouped by the classification in the seventh report of 
the Joint National Committee, 2003 (13). 
  To control the confounders, Cox’s proportional-hazards re-
gression was used to evaluate the association between the base-
line cholesterol and death from CVD. Confidence intervals were 
obtained by the Wald method and all reported P values are two 
sided. The chi-square test for trend was used to evaluate linear 
trends. Analyses were conducted using SAS version 9 (14).
RESULTS
Baseline characteristics are presented in Table 1. In total 12,740 
study participants, the average of age and BMI are 56.2 yr-old 
and 24.2 (kg/m
2) for both sexes, respectively (SD 8.38 in age, 18.49 
in BMI). During a follow-up of totally 73,064,487 person-years, 
98 men and 75 women died from CVD. Smoking history, drink-
ing history, high blood pressure, and HDL cholesterol have a lin-
ear trend with statistical significance. BMI and TC cholesterol 
show the U-shaped curve in the risk of death from CVD (Table 1).
  Fig. 1 displays the distribution of TC with 194 mg/dL in mean 
and 47.2 in SD. Table 2 indicates that the lowest group having 
TC < 160 mg/dL as well as the highest group having  >= 240 mg/ 
dL are associated with higher CVD mortality in Cox proportional 
hazards analysis adjusting for age, sex, smoking and drinking 
status, body mass index, level of blood pressure, TG and HDL 
cholesterol. Even if excluding TG and HDL cholesterol for con-
sidering over-adjustment (model 2 in Table 2), the trends as well 
as statistical significances were sustained. 
  Table 3 shows HRs and 95% CIs for CVD mortality by choles-
terol category. The crude and multivariate-adjusted HRs are 
grouped by sex. While the distribution of adjusted HRs shows 
the U-shaped curve, the adjusted HRs of the lowest cholesterol 
group (< 160 mg/mL) in a risk of CVD death are 1.55 (95% CI, 
0.93-2.59) for men and 1.31 (0.57-3.03) for women. In the high-
est cholesterol group (≥ 240 mg/dL), the adjusted HR in men 
only has the statistical significance (aHR 2.01, 95% CI 1.04-3.87). 
When a subgroup analysis in mortality from heart disease and 
stroke has conducted, all adjusted HRs by cholesterol groups 
and both sexes do not show a statistical significance, in spite of 
keeping the U-shaped distribution. 
DISCUSSION
CVD encompasses a wide range of disease including ischemic 
heart disease, coronary heart disease (e.g. heart attack), cerebro-
vascular disease (e.g. stroke), raised blood pressure, hyperten-
sion, rheumatic heart disease and heart failure (6). As CVD is 
ranked as the number one cause of mortality and is a major cause 
of morbidity world wide (1), CVD imposes high social costs, in-
cluding impaired quality of life and reduced economic activity, 
and accounts for a large share of health service resources (15). 
  In the general population, the relationship between hyperlip-
idemia (dyslipidemia) and CVD (predominantly CAD) is well 
established (16) and there are proven benefits of lipid-lowering 
with statins (6). While this study has several strengths, including 
a prospective design, large sample size, prolonged duration of 
follow-up, a large number of deaths, and actually complete mor-
Table 2. The crude and adjusted hazard ratios (cHR, aHR) with 95% confidence intervals (CIs) of total cholesterol in death by cardiovascular diseases in the study participants     
(n = 12,740)
Total Cholesterol (mg/dL) Deaths No.
cHR  
[95% CI]
aHR by model 1  
[95% CI] 
aHR by model 2  
[95% CI]
  P value 
  (χ2 trend)
< 160 54 4,793 1.60 [1.08, 2.37] 1.80 [1.08, 3.01] 1.92 [1.15, 3.20] < 0.001
160-199 46 2,596 1.00        - 1.00        - 1.00        - 
200-239 46 3,614 1.12 [0.76, 1.66] 1.30 [0.76, 2.20] 1.23 [0.72, 2.07]
≥ 240 27 1,737 1.37 [0.86, 2.17] 2.02 [1.13, 3.62] 1.85 [1.04, 3.29]
*model 1 (adjusted for age, sex, smoking and drinking history, body mass index, level of blood pressure, triglyceride, high density lipoprotein) and model 2 (adjusted for age, 
sex, smoking and drinking history, body mass index, and level of blood pressure).
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tality follow-up, the distribution of multivariable-adjusted HRs 
shows the U-shaped curve in Korean adults. Especially, the fact 
that low cholesterol was related to high mortality of CVD is as 
same as that of a Japanese study (9) in Table 4. 
  Similar inverse, ‘J’ or ‘U’-shaped relationships between lipid 
levels and all cause mortality have been reported in other pop-
ulations and are thought to reflect a high prevalence of co-mor-
bid disease in patients with low cholesterol levels (16, 17). In the 
Honolulu Heart Study of Japanese-Americans (18), low serum 
cholesterol was associated with increased mortality, but only 
among individuals with the risk factors of smoking, high alcohol 
consumption, and untreated hypertension. In other words, the 
association is not invariant, but appears to vary across popula-
tions of different social or lifestyle characteristics (7).
  Although the increase in mortality at low levels of TC was ex-
plained by chance, regression dilution bias, competing risks, 
Table 3. The crude and adjusted* hazard ratios (cHR, aHR) of total cholesterol level in the cardiovascualr mortalities by sex
Sex
Baseline Total Cholesterol level (mg/dL)
< 160 160-199 200-239 ≥ 240
Hazard ratio (95% CI)
Men
Cardiovascualr diseases, total mortality
   Crude
   Adjusted 
Heart diseases mortality
   Crude
   Adjusted
Stroke mortality
   Crude
   Adjusted
 
 
1.52 [0.99, 2.32]
1.55 [0.93, 2.59]
 
1.30 [0.60, 2.85]
1.55 [0.60, 3.96]
 
1.63 [0.98, 2.70]
1.54 [0.84, 2.85]
 
 
1.00
1.00
 
1.00
1.00
 
1.00
1.00
 
 
0.78 [0.47, 1.27]
0.84 [0.45, 1.55]
 
0.90 [0.39, 2.09]
0.79 [0.26, 2.37]
 
0.72 [0.39, 1.33]
0.86 [0.41, 1.80]
 
 
1.21 [0.66, 2.22]
2.01 [1.04, 3.87]
 
1.30 [0.46, 3.74]
2.27 [0.75, 6.92]
 
1.17 [0.56, 2.45]
1.89 [0.83, 4.29]
Women
Cardiovascualr diseases, total mortality
   Crude
   Adjusted
Heart diseases mortality
   Crude
   Adjusted 
Stroke mortality
   Crude
   Adjusted
 
 
1.12 [0.63, 2.00]
1.31 [0.57, 3.03]
 
1.00 [0.38, 2.62]
1.69 [0.47, 6.12]
 
1.20 [0.58, 2.49]
1.11 [0.37, 3.32]
 
 
1.00
1.00
 
1.00
1.00
 
1.00
1.00
 
 
1.09 [0.67, 1.78]
0.97 [0.51, 1.86]
 
1.85 [0.89, 3.85]
2.08 [0.80, 5.44]
 
0.74 [0.37, 1.46]
0.51 [0.19, 1.36]
  
  
1.37 [0.78, 2.42]
1.12 [0.53, 2.38]
 
1.12 [0.43, 2.95]
0.47 [0.10, 2.09]
 
1.54 [0.76, 3.11]
1.76 [0.72, 4.29]
*adjusted for age, smoking and drinking history, body mass index, level of blood pressure, high density lipoprotein cholesterol, and triglyceride.
Table 4. Comparison of adjusted* hazard ratios (aRR) of total cholesterol level in the cardiovascualr mortalities by sex between Korean and Japanese people [Ref: 9]
Sex
Baseline Total Cholesterol level (mg/dL)
< 160 160-199 200-239 ≥ 240
Hazard ratio (95% CI)
Male
Cardiovascualr diseases, total mortality
   Adjusted in Korean
   Adjusted in Japanese
Heart diseases mortality
   Adjusted in Korean
   Adjusted in Japanese
Stroke mortality
   Adjusted in Korean
   Adjusted in Japanese
 
 
1.55 [0.93, 2.59]
1.38 [1.13, 1.66]
 
1.49 [0.59, 3.78]
1.36 [0.76, 2.46]
  
1.58 [0.86, 2.91]
1.21 [0.66, 2.21]
1.00
 
 
 
0.83 [0.45. 1.53]
1.09 [0.88, 1.34]
 
0.80 [0.27, 2.42]
1.04 [0.54, 2.01]
 
0.85 [0.41, 1.77]
0.99 [0.53, 1.82]
 
 
1.97 [1.02, 3.78]
1.21 [0.82, 1.78]
 
2.34 [0.78, 7.06]
2.14 [0.81, 5.65]
 
1.81 [0.80, 4.08]
0.98 [0.29, 3.23]
Female
Cardiovascualr diseases, total mortality
   Adjusted in Korean
   Adjusted in Japanese
Heart diseases mortality
   Adjusted in Korean
   Adjusted in Japanese
Stroke mortality
   Adjusted in Korean
   Adjusted in Japanese
 
 
1.29 [0.56, 2.95]
1.42 [1.02, 2.00]
 
1.66 [0.46, 5.94]
1.34 [0.54, 3.35]
 
1.08 [0.36, 3.21]
1.84 [0.71, 4.76]
1.00  
 
0.98 [0.51, 1.87]
0.93 [0.73, 1.17]
 
2.08 [0.80, 5.42]
0.78 [0.42, 1.42]
 
0.51 [0.19, 1.37]
1.29 [0.68, 2.44]
 
 
1.13 [0.54, 2.39]
0.93 [0.67, 1.30]
 
0.47 [0.11, 2.10]
0.39 [0.11, 1.30]
 
1.78 [0.73, 4.30]
1.52 [0.66, 3.48]
*adjusted for age, smoking and drinking history, body mass index, level of blood pressure, and high density lipoprotein cholesterol.Bae J-M, et al.  •  Low Cholesterol & CVD Mortality in Korean Adults
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cause-effect, effect-cause, and residual confounding such as 
smoking (17), the terms of ‘reverse epidemiology’ and ‘obesity 
paradox’ (19, 20) in marked contrast to the effects of TC or obe-
sity on mortality in the general population, especially the Fram-
ingham paradigm (21), have been proposed. Associations com-
patible with the concept of “reverse epidemiology” have been 
described in several other chronic conditions such as end-stage 
renal disease, malignancies, chronic obstructive lung disease, 
AIDS as well as in the elderly (22). As same as the results of this 
study, Casiglia et al. (23) reported that the higher the TC levels, 
the lower mortality in the elderly. In addition, Strandberg et al. 
(24) suggested that low serum cholesterol level in midlife pre-
dicted not only better survival but also better physical function 
and quality of life (QOL) in old age. 
  Interestingly, Table 3 showed that the adjusted HR of heart 
disease mortality was in the opposite direction between men 
and women, especially in TC over 240 mg/dL (2.27 in men vs 
0.47 in women). Japanese in the same level of TC in Table 4 also 
showed the same fact (2.14 in men vs 0.39 in women). While the 
CVD mortality in men are generally higher than in women, fur-
ther studies for explaining this phenomenon will be needed.  
  The fact that only the multivariable-adjusted HR in men has 
the statistical significance should be interpreted carefully because 
this study has a number of limitations. First limitation is that re-
sults were based on a one-time measurement of serum lipids. 
In longitudinal studies the use of baseline measurements only 
may underestimate the associations between usual risk factors 
and CVD mortality due to regression dilution effects (25). Second 
limitation is that TC levels in this study were measured in the 
non-fasting state. Although similar results were obtained when 
analyses were repeated with non-fasting serum (26), subjects 
would be grouped into higher TC level. Based on this fact, cal-
culated HRs would be assumed as under-estimated with toward 
the null. Third limitation is the issue of reverse-causality because 
some underlying diseases could influence the level of lipid. To 
controlling this bias, authors applied to exclude members having 
previous history of cardiovascular disease on entry. Last limita-
tion is that the “healthy peopler” would have a higher chance to 
register as a cohort participant in general population (27). The 
effect on mortality might have been slightly underestimated by 
the increased level of TC during follow-up. 
  CVD is multi-factorial in its causation and lifestyle changes 
are the basis of any treatment strategy, with patients often requir-
ing behavioral counseling (6). Considering reductions in CVD 
mortality with statins, there have still been controversies regard-
ing the truly long-term prognostic value of low cholesterol on 
CVD mortality, especially in older individuals (5, 28). Based on 
the results of this study, caution should be taken in prescribing 
statins for primary prevention among people at low cardiovas-
cular risk. 
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